Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many cancer drugs have been approved for use in (a) 2021-2022, (b) 2022-2023, (c) 2023-2024 and (d) 2024-2025.
The following table shows the number of cancer medicines that have been recommended by the National Institute for Health and Care Excellence in each of the last four full business years:
Year | Number of recommendations |
2021/22 | 36 |
2022/23 | 36 |
2023/24 | 28 |
2024/25 | 37 |
The information provided includes all medicines recommended for routine use for some or all of the eligible patient population, and medicines recommended for managed access through the Cancer Drugs Fund.